EMEA-000783-PIP01-09-M06
Key facts
Invented name |
Trulicity
|
Active substance |
dulaglutide
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0409/2021
|
PIP number |
EMEA-000783-PIP01-09-M06
|
Pharmaceutical form(s) |
Solution for injection (pre-filled pen)
|
Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|